Following his PhD, he worked at Harvard and
Case Western Reserve University. In 1942, he went to work for Wellcome Research Laboratories at
Tuckahoe, where he began working with
Gertrude Elion in 1944. Drugs Hitchings' team worked on included
2,6-diaminopurine (a compound to treat
leukemia) and p-chlorophenoxy-2,4-diaminopyrimidine (a
folic acid antagonist). According to his Nobel Prize autobiography, :The line of inquiry we had begun in the 1940s [also] yielded new drug therapies for
malaria (
pyrimethamine), leukemia (
6-mercaptopurine and
thioguanine),
gout (
allopurinol),
organ transplantation (
azathioprine) and
bacterial
infections (
co-trimoxazole (trimethoprimA)). The new knowledge contributed by our studies pointed the way for investigations that led to major
antiviral drugs for
herpes infections (
acyclovir) and
AIDS (
zidovudine). In 1967 Hitchings became vice president in Charge of Research of Burroughs-Wellcome. He became Scientist Emeritus in 1976. He also served as adjunct professor of pharmacology and of experimental medicine from 1970 to 1985 at
Duke University. Hitchings founded the Triangle Community Foundation in 1983. Hitchings is a member of the Medicinal Chemistry Hall of Fame. == Personal life ==